| Product Code: ETC8855973 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In the Poland allopurinol market, imports experienced significant growth from 2023 to 2024, with a growth rate of 16.76%. The compound annual growth rate (CAGR) for imports from 2020 to 2024 stood at 5.53%. This import momentum can be attributed to increased demand for allopurinol within the Polish market, indicating a notable shift in consumer preferences or potentially evolving treatment protocols.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Poland Allopurinol Market Overview |
3.1 Poland Country Macro Economic Indicators |
3.2 Poland Allopurinol Market Revenues & Volume, 2021 & 2031F |
3.3 Poland Allopurinol Market - Industry Life Cycle |
3.4 Poland Allopurinol Market - Porter's Five Forces |
3.5 Poland Allopurinol Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 Poland Allopurinol Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Poland Allopurinol Market Revenues & Volume Share, By Dosage Form, 2021 & 2031F |
3.8 Poland Allopurinol Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.9 Poland Allopurinol Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Poland Allopurinol Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of gout and related disorders in Poland |
4.2.2 Rising health awareness and focus on preventive healthcare |
4.2.3 Growing geriatric population in the country |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for drug approvals and marketing |
4.3.2 Availability of alternative treatment options for gout |
4.3.3 Price fluctuations of allopurinol in the market |
5 Poland Allopurinol Market Trends |
6 Poland Allopurinol Market, By Types |
6.1 Poland Allopurinol Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 Poland Allopurinol Market Revenues & Volume, By Drug Class, 2021- 2031F |
6.1.3 Poland Allopurinol Market Revenues & Volume, By Antigout Agents, 2021- 2031F |
6.1.4 Poland Allopurinol Market Revenues & Volume, By Antihyperuricemic Agents, 2021- 2031F |
6.2 Poland Allopurinol Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Poland Allopurinol Market Revenues & Volume, By Gout, 2021- 2031F |
6.2.3 Poland Allopurinol Market Revenues & Volume, By Kidney Stones, 2021- 2031F |
6.2.4 Poland Allopurinol Market Revenues & Volume, By Others, 2021- 2031F |
6.2.5 Poland Allopurinol Market Revenues & Volume, By Demographic, 2021- 2031F |
6.2.6 Poland Allopurinol Market Revenues & Volume, By Adult, 2021- 2031F |
6.2.7 Poland Allopurinol Market Revenues & Volume, By Pediatric, 2021- 2031F |
6.3 Poland Allopurinol Market, By Dosage Form |
6.3.1 Overview and Analysis |
6.3.2 Poland Allopurinol Market Revenues & Volume, By Intravenous Powder for Injection, 2021- 2031F |
6.3.3 Poland Allopurinol Market Revenues & Volume, By Oral Tablet, 2021- 2031F |
6.4 Poland Allopurinol Market, By End-Users |
6.4.1 Overview and Analysis |
6.4.2 Poland Allopurinol Market Revenues & Volume, By Clinic, 2021- 2031F |
6.4.3 Poland Allopurinol Market Revenues & Volume, By Hospital, 2021- 2031F |
6.4.4 Poland Allopurinol Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Poland Allopurinol Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 Poland Allopurinol Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.5.3 Poland Allopurinol Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.5.4 Poland Allopurinol Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
7 Poland Allopurinol Market Import-Export Trade Statistics |
7.1 Poland Allopurinol Market Export to Major Countries |
7.2 Poland Allopurinol Market Imports from Major Countries |
8 Poland Allopurinol Market Key Performance Indicators |
8.1 Number of new clinical studies or trials on allopurinol in Poland |
8.2 Prescription rate of allopurinol compared to other gout medications |
8.3 Patient adherence and compliance rates with allopurinol therapy |
8.4 Prescription patterns by healthcare professionals for allopurinol |
8.5 Frequency of adverse events or side effects reported for allopurinol usage |
9 Poland Allopurinol Market - Opportunity Assessment |
9.1 Poland Allopurinol Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 Poland Allopurinol Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Poland Allopurinol Market Opportunity Assessment, By Dosage Form, 2021 & 2031F |
9.4 Poland Allopurinol Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.5 Poland Allopurinol Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Poland Allopurinol Market - Competitive Landscape |
10.1 Poland Allopurinol Market Revenue Share, By Companies, 2024 |
10.2 Poland Allopurinol Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |